Ocular Therapeutix, Inc. · NASDAQ:OCUL

Anderman Todd sold 11,984 Ocular Therapeutix, Inc. shares (Form 4)

Traded Oct 8, 2026 · Filed Oct 13, 2026

On Oct 8, 2026, Anderman Todd (Chief Legal Officer) sold 11,984 Ocular Therapeutix, Inc. shares at US$7.29 for US$87,363 under a trading plan, leaving 140,484 shares. Filed Oct 13, 2026 (Form 4).

Sold
11,984 shares
Price
US$7.29
Value
US$87,363
Holding after
140,484 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 8, 2026Common StockSale11,984US$7.29140,484Direct

Source

View original at SEC

Related